Self-Referral Drives Extra Prostate Biopsy Activity, Study Suggests

A Medicare claims analysis compared biopsy trends in men referred for biopsy analysis by urologists who use a pathology lab to which they have a financial association, and those who see urologists that order biopsies at unassociated labs.

Researchers reported data this month suggesting self-referring urologists frequently submit additional biopsy samples compared to non-self-referring doctors and more often perform biopsies on men less likely to have a positive diagnosis of prostate cancer.

The study was published by Jean Mitchell, professor of public policy at Georgetown University, in the April issue of the...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Policy & Regulation

More from Medtech Insight

Waters’ Purchase Of BD Biosciences & Dx Brings Growth Potential Alongside Trade-Offs

 
• By 

Waters Corp. will acquire Becton Dickinson’s Biosciences and Diagnostics business for $17.5bn, doubling its TAM to $40B. Analysts praise the flow cytometry addition but see weaker growth in diagnostics.

European MedTech Keeps Calm Despite US Threats Of 30% Tariffs

 

MedTech Europe wants the EU to continue its commitment to reach a negotiated tariff solution with the US and measured restraint amid escalating trade tensions.

Medtech Will Benefit From Boost To EU’s Quantum Technology Initiative

 

The European Commission is focusing on how tiny particles behave to help create an EU industrial “powerhouse.”